Selinexor: Changing the paradigm in patients with TP53 wild-type endometrial cancer?

Mohamed A. Gouda, Kyaw Z. Thein

Research output: Contribution to journalComment/debatepeer-review

Fingerprint

Dive into the research topics of 'Selinexor: Changing the paradigm in patients with TP53 wild-type endometrial cancer?'. Together they form a unique fingerprint.

Medicine & Life Sciences